Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Eclinicalmedicine|March 4, 2025
Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysisAndri Papakonstantinou, Guillermo Villacampa, Victor Navarro, et al.
Acta Oncologica (Stockholm, Sweden)|May 7, 2024
Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II studyIvar Hompland, Kjetil Boye, Anne Marit Wiedswang, et al.
Journal of Internal Medicine|August 29, 2023
Sarcoma care in the era of precision medicineKarin Wallander, Ingegerd Öfverholm, Kjetil Boye, et al.
International Journal of Cancer|April 28, 2022
The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral centerSara Renberg, Yifan Zhang, Fredrik Karlsson, et al.
Rare Tumors|March 3, 2025
Complete remission in a rare pelvic angiosarcoma with liposomal doxorubicin: A comprehensive case report and review of literatureTruls Gråberg, Andri Papakonstantinou, Felix Haglund de Flon, et al.
Cancer Treatment Reviews|February 26, 2022
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysisAndri Papakonstantinou, Nadia Saoudi Gonzalez, Isabel Pimentel, et al.
The Lancet Regional Health. Europe|December 20, 2024
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialAlexios Matikas, Andri Papakonstantinou, Sibylle Loibl, et al.
European Journal of Cancer (Oxford, England : 1990)|April 3, 2026
Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysisPanagiotis Filis, Georgios Markozannes, Dimitrios Salgkamis, et al.
Cancer Medicine|July 16, 2025
Prognostic Factors in Newly Diagnosed High-Grade Osteosarcoma-A Systematic ReviewElisa Tirtei, Sascha Wilk Michelsen, Lianne M Haveman, et al.
The British Journal of Surgery|September 27, 2023
Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapyMarta Berndsen, Sara Renberg, Toto Hølmebakk, et al.
Pageof 4